Disclosed herein are certain thiadiazolyl derivatives of Formula (I), (II), (III), or (IV): (I), (II), (III), (IV) that inhibit DNA Polymerase Theta (Polθ) activity, in particular inhibit Polθ activity by inhibiting ATP dependent helicase domain activity of Polθ. Also, disclosed are pharmaceutical compositions comprising such compounds and methods of treating and/or preventing diseases treatable by inhibition of Polθ such as cancer, including homologous recombination (HR) deficient cancers.
本文披露了某些Formula (I), (II), (III), 或 (IV)的
噻二唑衍
生物:(I), (II), (III), (IV),它们抑制
DNA聚合酶Theta (Polθ)的活性,特别是通过抑制Polθ的
ATP依赖的解旋酶结构域活性来抑制Polθ的活性。此外,还披露了包含这些化合物的药物组合物以及治疗和/或预防通过抑制Polθ可治疗的疾病的方法,例如癌症,包括同源
重组 (HR) 缺陷癌症。